Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 5388 of 6351
-
New risk tool aims to take the guesswork out of sarcoma treatment choices
Knowledge-focused OngoingThe goal of this clinical trial is to assess the (cost-)effectiveness of a personalised risk assessment tool (PERSARC) to increase patients' knowledge about risks and benefits of treatment options and to reduce decisional conflict in comparison with usual care in high-grade extre…
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:17 UTC
-
Genetic deep dive uncovers hidden clues in rare bone disease
Knowledge-focused CompletedThis study is being done to determine if cryptic alterations exist within or near to the ALPL gene in patients with a clinical diagnosis of hypophosphatasia, but without identifiable alteration on commercial testing. Additionally, the study aims to characterize functional effects…
Sponsor: Children's Mercy Hospital Kansas City • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Proton beam therapy tested for liver cancer – early results show promise and risks
Disease control Stopped earlyThis phase II trial studies the effect of stereotactic body proton radiotherapy in treating patients with liver cancer. Proton radiotherapy is a type of treatment that uses high-energy beams to treat tumors.
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental combo for bile duct cancer shows promise in tiny trial
Disease control CompletedThe purposed of this research is to study the safety and clinical activity of the combination of durvalumab and a CSF-1R inhibitor (SNDX-6352) in people with Intrahepatic Cholangiocarcinoma.
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Gut bugs may boost flu vaccine power
Knowledge-focused OngoingThis study evaluates the association between gut microbiome and dietary determinants and vaccine response. This study aims to learn if diet and the microbes (such as bacteria and viruses) found in your gut affect the body's immune response to the influenza vaccine.
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Scientists pinpoint ideal painkiller dose for diabetic foot operations
Symptom relief OngoingThe purpose of this study was to determine the minimum effective dose of a local anesthetic for proper anesthesia for popliteal sciatic nerve block under ultrasound guidance in patients undergoing surgery for diabetic foot disease.
Sponsor: Seoul National University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
Zapping nerves with ultrasound: a new hope for heart failure?
Disease control CompletedThe purpose is to evaluate the renal denervation system (PRDS-001) for controlling sympathetic nerve over-activation in patients with heart failure, and for its safety in such patients.
Sponsor: Otsuka Medical Devices Co., Ltd. Japan • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
3D tool may boost satisfaction in breast reconstruction decisions
Symptom relief OngoingThe purpose of this study is to find out whether using an interactive 3D tool during a standard surgical consultation can lead to greater patient satisfaction with the information provided about breast reconstruction options than the standard consultation alone. The study researc…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
Can a sleep drug curb cigarette cravings?
Symptom relief CompletedThe purpose of this study is to assess the impact of suvorexant on established measures of smoking relapse risk (craving,withdrawal, stress reactivity, latency to self-administration) and to validate the somnolent effect of suvorexant on sleep metrics in a sample of individuals w…
Phase 2 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New implant aims to silence severe ringing in the ears
Symptom relief CompletedResearchers are gathering information on the safety and effectiveness of a novel device called the Tinnitus Implant System for the treatment of tinnitus.
Sponsor: Matthew L. Carlson, M.D. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New cholesterol drug shows promise for seniors in 6-Month study
Disease control CompletedA prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older
Sponsor: Dong Wha Pharmaceutical Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Rare disease detection: new study measures porphyria prevalence in symptomatic patients
Knowledge-focused CompletedTo determine the proportion of patients suffering from acute hepatic porphyria (AHP) from different hospital departments and referred to an internist referent for a suggestive clinical picture with a first negative etiological assessment.
Sponsor: Association pour la Recherche en Medecine Interne • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Hidden gene changes may raise heart risk even after quitting smoking
Knowledge-focused CompletedIn order to identify the association between clonal hematopoiesis of indeterminate potential (CHIP) and cardiovascular risks after smoking cessation, this study intends to recruit ACS patients undergoing complete revascularization and perform whole-exome sequencing for enrolled p…
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:27 UTC
-
No-Needle blood pressure monitor put to the test
Knowledge-focused OngoingTo evaluate the clinical performance of the Hypotension Prediction Index obtained from the continuous, non-invasive Clear Sight monitor.
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New blood test could improve how we monitor heart medications
Diagnosis CompletedThe purpose of this study is to test a novel diagnostic immunoassay of platelet function and compare it to the current gold standard platelet function assay by testing the response to aspirin and clopidogrel in a group of healthy volunteers and severely obese individuals and comp…
Early phase 1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
Gut bacteria may hold key to better heart health after Weight-Loss surgery
Knowledge-focused Recruiting nowMetabolic surgery is an emerging option to treat obesity-related metabolic diseases (e.g., type 2 diabetes) and prevent cardiovascular disease (CVD). Metabolic surgery can profoundly alter the gut microbiota; meanwhile, gut microbiota may affect surgical outcomes. Longitudinal st…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Can cancer patients recover at home with remote monitoring?
Knowledge-focused CompletedThis study is evaluating if a program that involves remote monitoring and home-based care may improve the post-discharge care of recently hospitalized patients with advanced cancer. The Supportive Oncology Care at Home intervention consists of three key components: 1. Remote pa…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Virtual reality cycling may sharpen brain function after TBI
Knowledge-focused CompletedAerobic exercise is a promising treatment modality for cognition in persons with TBI, but effects are consistently small. This study aims to investigate the effect of difference environments during moderate intensity cycling sessions on cognition.
Sponsor: Kessler Foundation • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:35 UTC
-
New anemia drug for MDS and myeloma patients shows early promise but trial halted
Disease control Stopped earlyThis Phase 1/2, open-label, dose-finding study is intended to evaluate the safety and tolerability, PK, PD, and efficacy of INCB000928 administered as monotherapy in participants with MDS or MM who are transfusion-dependent or present with symptomatic anemia.
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to uncover Alzheimer's clues in down syndrome
Knowledge-focused Recruiting nowProgressive age-related cognitive deficits occurring in both AD and DS have been connected to the degeneration of several neuronal populations, but mechanisms are not fully elucidated. The most consistent neuronal losses throughout the progression of AD are seen in cholinergic ne…
Phase 2 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC